Email This Article
Headlines & Perspectives
Rejection Is Always Possible, but BioTransplant Could Take
By
Adam Feuerstein
05/01/01 - 06:17 PM EDT
The little company mixes immune systems to combat cancer, improve organ transplants.
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,452.68 | 1,109.24 | 2,185.03 | 33.23 |
Oil *
77.73
|
|
DOWN
18.90
|
UP
0.38
|
UP
9.22
|
UP
0.48
|
10 Yr
3.32%
SPDR Gold
119.18
|
|
-0.18%
|
+0.03%
|
+0.42%
|
+1.47%
|
Data delayed 20 minutes |


Connect with TheStreet